logo
Plus   Neg
Share
Email

Lockheed Martin Boosts FY19 Outlook - Quick Facts

While reporting financial results for the third quarter on Tuesday, Lockheed Martin Corp. (LMT) raised its earnings and net sales guidance for the full-year 2019, and initiated net sales outlook for the full-year 2020.

For fiscal 2019, the company now expects earnings of about $21.55 per share, up from prior guidance range of $20.85 to $21.15 per share.

Net sales are now projected to be about $59.10 billion, up from prior guidance range of $58.25 billion to $59.75 billion.

On average, analysts polled by Thomson Reuters expect the company to report earnings of $21.21 per share on revenues of $59.19 billion for the year. Analysts' estimates typically exclude special items.

Looking ahead to fiscal 2020, the company now projects net sales to increase to about $62.0 billion, while analysts projects revenues of $62.82 billion for the year.

"As we look ahead to 2020, we remain focused on providing innovative solutions for our customers, investing for long-term growth, and generating value for our shareholders," said Lockheed Martin Chairman, President and CEO Marillyn Hewson.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
NBCUniversal unveiled Peacock, a free premium ad-supported streaming service with subscription tiers offering more than 600 movies and 400 series. Peacock will be available on April 15 for Comcast's Xfinity X1 and Flex customers and on July 15 for the rest of the country. NBC is offering Peacock... The number of Amazon Prime members in the U.S. is growing slowly, but steadily, a recent study has shown. According to the survey by the Consumer Intelligence Research Partners, LLC or CIRP, the number of Amazon Prime members in the U.S. is estimated to have risen to 112 million in December 2019 from just over 100 million in the same period of the prior year. Medical device manufacturer Cardinal Health will soon recall certain Level 3 surgical gowns or PreSource procedural packs that contain these gowns following warning that they may not be sterile, the U.S. Food and Drug Administration said in a statement. The health regulator said it is working with the company to find out the specific product lots that are impacted.
Follow RTT
>